Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate.
Level 5 - mechanism / opinion, no new human data
Mechanism-based reasoning and hypothesis paper proposing clinical applications without new empirical data.
PubMed 8692051 · doi:10.1016/s0306-9877(96)90007-9
What was done
This theoretical paper synthesizes known physiological actions of magnesium and taurine from animal and clinical literature to propose a rationale for magnesium taurate as an oral supplement or parenteral therapeutic agent.
What was found
No original empirical or quantitative data were reported in the abstract. The author notes that magnesium reduces cytoplasmic free calcium, conferring antihypertensive, anti-atherosclerotic, anti-arrhythmic, and antithrombotic properties, while taurine exerts parallel effects, retards cholesterol-induced atherogenesis, prevents arrhythmias, stabilizes platelets, and both may improve insulin sensitivity.
Why it matters
It introduces a conceptual framework suggesting that the combined complex magnesium taurate could serve as a vascular-protective supplement or parenteral alternative to magnesium sulfate in acute myocardial infarction, pre-eclampsia, and diabetes.
Limits
The abstract describes a purely hypothesis-driven paper without experimental testing, empirical measurements, or clinical trial validation. Proposed clinical uses in conditions like pre-eclampsia or acute myocardial infarction are theoretical extrapolations.
Cited by
- supports Taurine is involved in cellular calcium regulation, including in arterial wall muscle cells and blood platelets.